<bill session="112" type="h" number="6190" updated="2022-03-01T06:10:55Z">
  <state datetime="2012-12-12T17:20:10-05:00">PROV_KILL:SUSPENSIONFAILED</state>
  <status>
    <unknown datetime="2012-12-12T17:20:10-05:00"/>
  </status>
  <introduced datetime="2012-07-25"/>
  <titles>
    <title type="short" as="reported to house">Asthma Inhalers Relief Act of 2012</title>
    <title type="short" as="introduced">Asthma Inhalers Relief Act of 2012</title>
    <title type="display">Asthma Inhalers Relief Act of 2012</title>
    <title type="official" as="introduced">To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.</title>
  </titles>
  <sponsor bioguide_id="B001248"/>
  <cosponsors>
    <cosponsor bioguide_id="B000213" joined="2012-07-25"/>
    <cosponsor bioguide_id="C001051" joined="2012-07-25"/>
    <cosponsor bioguide_id="M001142" joined="2012-07-25"/>
    <cosponsor bioguide_id="P000373" joined="2012-07-25"/>
    <cosponsor bioguide_id="R000573" joined="2012-07-25"/>
  </cosponsors>
  <actions>
    <action datetime="2012-07-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2012-07-25" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2012-07-27">
      <text>Referred to the Subcommittee on Energy and Power.</text>
    </action>
    <action datetime="2012-09-14">
      <text>Reported by the Committee on Energy and Commerce. H. Rept. 112-673.</text>
    </action>
    <calendar datetime="2012-09-14" calendar="Union" number="485">
      <text>Placed on the Union Calendar, Calendar No. 485.</text>
    </calendar>
    <action datetime="2012-12-12T13:53:15-05:00">
      <text>Mr. Burgess moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2012-12-12T13:53:37-05:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H6724-6728" label="consideration"/>
      <reference ref="CR H6724" label="text of measure as reported in House"/>
    </action>
    <action datetime="2012-12-12T13:53:40-05:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 6190.</text>
    </action>
    <action datetime="2012-12-12T14:31:50-05:00">
      <text>At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.</text>
    </action>
    <action datetime="2012-12-12T17:12:55-05:00">
      <text>Considered as unfinished business.</text>
      <reference ref="CR H6740-6741" label="consideration"/>
    </action>
    <vote how="roll" type="vote" roll="623" datetime="2012-12-12T17:20:10-05:00" where="h" result="fail" suspension="1" state="PROV_KILL:SUSPENSIONFAILED">
      <text>On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 229 - 182 (Roll no. 623).</text>
    </vote>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Referral"/>
    <committee code="HSIF03" name="House Energy and Commerce" subcommittee="Energy, Climate and Grid Security" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Environmental protection"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Air quality"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Climate change and greenhouse gases"/>
    <term name="Environmental Protection Agency (EPA)"/>
    <term name="Environmental regulatory procedures"/>
    <term name="Health technology, devices, supplies"/>
  </subjects>
  <amendments/>
  <summary date="2012-11-13T18:28:10Z" status="Reported to House without amendment">(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.

Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.

Terminates this Act on August 1, 2013.</summary>
  <committee-reports>
    <report>H. Rept. 112-673</report>
  </committee-reports>
</bill>
